|
PF-60302 |
REXULTI 1 mg Comprimidos recubiertos |
2026-11-02 |
|
Lundbeck America Central, S.A. |
Japón
|
Centro Distribuidor, Sociedad Anónima |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-58160 |
CIPROX (0.2% P/V) Solución inyectable intravenosa para perfusión |
2025-04-21 |
|
Otsuka Pharmaceutical India Private Limited |
India
|
ARS Médica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-58332 |
LENIOL 1% (p/v) Solución inyectable intravenosa para perfusión |
2025-06-23 |
|
Otsuka Pharmaceutical India Private Limited |
India
|
ARS Médica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-58442 |
DIAMIN Solución inyectable intravenosa para perfusión |
2025-08-05 |
|
Otsuka Pharmaceutical India Private Limited |
India
|
ARS Médica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-58614 |
TENAFLOX 0.5% (p/v) Solución inyectable intravenosa para perfusión |
2025-09-29 |
|
Otsuka Pharmaceutical India Private Limited |
India
|
ARS Médica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59219 |
SUPERAMP Solución inyectable |
2026-03-25 |
|
Otsuka Pharmaceutical India Private Limited |
India
|
Aarsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59750 |
5D GLUCOSA Otsuka (50 g/L) Solución inyectable para perfusión |
2026-08-02 |
|
Otsuka Pharmaceutical India Private Limited |
India
|
Aarsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59569 |
CLORURO DE SODIO Otsuka (0.9% p/v) Solución inyectable para perfusión |
2026-06-11 |
|
Otsuka Pharmaceutical India Private Limited |
India
|
Aarsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60267 |
DNS Solución inyectable para perfusión |
2026-10-26 |
|
Otsuka Pharmaceutical India Private Limited |
India
|
Aarsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60608 |
CELEMIN 10-PLUS Solución inyectable para perfusión |
2027-01-18 |
|
Otsuka Pharmaceutical India Private Limited |
India
|
Aarsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|